University of Thessaly (UTH)
The role of adipose tissue in metabolic disorders and molecular pathways that affect its function
Abstract
dc:descriptionThe aim of this thesis is to expand the current knowledge on the role of adipose tissue (AT) on metabolic disorders and to research the molecular pathways that affect its function. In this light, we performed two narrative reviews. Initially, the crosstalk between AT and the vascular system and how this can affect the onset and progression of metabolic diseases was investigated. In a second narrative review, the angiogenic factors that affect AT and pharmacological approaches that could be used in the treatment of obesity and its accompanying co-morbidities were described. Moreover, current bioengineering approaches that could be employed in the fight against obesity and consequent metabolic diseases are suggested. Hence this information led to testing the properties of a new, natural, Histogel-based bioscaffold to support the proliferation and differentiation of white AT to into brown-like AT, a more metabolically active version of fat. As AT is affected by the cytokines of other tissues, irisin, a myokine, and its role on metabolic disorders was explored. Based on accumulating evidence on the implication of irisin in cancer a systematic review was performed, with the aim to elucidate how irisin is involved in the progression of cancer and if it can constitute a valid biomarker for its diagnosis. Finally, the role of irisin on AT and how it affects its metabolic state was investigated. The results of the current thesis suggest that the communication between vascular system and adipose tissue should be considered, when pharmacological approaches are employed for the treatment of metabolic disorders. Moreover, the use of biological scaffolds is suggested, that could result in increased gain of brown adipose tissue (increased metabolic activity) and be part of the treatment of obesity and accompanying metabolic disorders. The results demonstrate that irisin is involved in cancer by modulating cell proliferation and tumor invasion through several signaling pathways and can also be a good biomarker for the diagnosis of cancer. Finally, the role of irisin in the regulation of lipolysis and thermogenesis in vitro is presented. Taken together, these results indicate that adipose tissue is an excellent medium for pharmacological or biomedical interventions for the treatment of metabolic disorders.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Vliora, Maria
- Βλιώρα, Μαρία
Subjects
dc:subject × 21- Λιπώδης ιστός
- Μεταβολικές ασθένειες
- Ικριώματα μηχανικής ιστών (scaffolds)
- Ιρισίνη
- Καρκίνος
- Αγγειογένεση
- VEGF (Aγγειογενετικός ενδοθηλιακός αναπτυξιακός παράγοντας )
- FNDC5
- Φαιός λιπώδης ιστός
- Λευκός λιπώδης ιστός
- Adipose tissue
- brown adipose tissue
- White adipose tissue
- Metabolic disorders
- Irisin
- Cancer
- Angiogenesis
- Ιατρική Βιοτεχνολογία
- Ιατρική και Επιστήμες Υγείας
- Medical Biotechnology
- Medical and Health Sciences
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/52424